| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +6% |
| 3Y CAGR | -3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -14% |
| 3Y CAGR | +208% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹17,003.00 -53.00 (0.31%) | 21,873.61 | 60.09 | 11.67 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹8,386.50 -37.00 (0.44%) | 21,062.88 | 112.32 | 24.13 | ||
PfizerPFIZER | ₹4,542.10 +24.10 (0.53%) | 20,680.03 | 28.62 | 4.92 | ||
₹1,386.10 +1.70 (0.12%) | 19,200.58 | 29.65 | 4.92 |